Cryo-EM structures of Nav channels with pore-blocking inhibitors resolved
| PDB ID | Emd ID | Drug ID | Reference | Drug name | Drug Qscores | Ave.pore Qscores | Subtype |
|---|---|---|---|---|---|---|---|
| 7W77 | 32341 | 966 | Li et al. (2022) | Bulleyaconitine A | 0.391 | 0.52 | Human Nav1.3 |
| 7W7F | 32343 | 8DE | Li et al. (2022) | ICA-121431 | 0.409 | 0.489 | Human Nav1.3 |
| 6UZ0 | 20949 | K4D | Jiang et al. (2020) | Flecainidea | 0.557 | 0.527 | rat Nav1.5 |
| 6LQA | 942 | QDN | Li et al. (2021) | Quinidine | 0.529 | 0.523 | Human Nav1.5 |
| 7FBS | 31519 | 4Y4 | Jiang et al. (2021) | Propafenone | 0.556 | 0.57 | rat Nav1.5 |
| 8F6P | 28887 | XHO | Lenaeus et al. (2023) | Ranolazine | 0.512 | 0.556 | rat Nav1.5 |
| 8T6L | 41071 | YIJ | Tonggu et al. (2024) | Batrachotoxin, Analog BTX-B | 0.253, 0.31 | 0.545 | rat Nav1.5 |
| 7XM9 | 33292 | G2E | Zhang et al. (2022) | XEN-907 | 0.483 | 0.541 | Human Nav1.7 |
| 7XMF | 33295 | G2W | Zhang et al. (2022) | IN2 | 0.463 | 0.563 | Human Nav1.7 |
| 7XMG | 33296 | G4I | Zhang et al. (2022) | TCN-1752 | 0.57 | 0.542 | Human Nav1.7 |
| 8I5B | 35193 | OJ0 | Wu et al. (2023) | Bupivacaine | 0.4 | 0.634 | Human Nav1.7 |
| 8I5G | 35194 | T70 | Wu et al. (2023) | PF-05089771 | 0.64 | 0.647 | Human Nav1.7 |
| 8I5X | 35197 | T7F | Wu et al. (2023) | Vinpocetine | 0.494 | 0.604 | Human Nav1.7 |
| 8I5Y | 35198 | TB4 | Wu et al. (2023) | Vixotrigine | 0.577 | 0.657 | Human Nav1.7 |
| 8J4F | 35975 | UK0 | Wu et al. (2023) | Hardwickii acid | 0.555 | 0.594 | Human Nav1.7 |
| 8S9B | 40238 | LQO | Wu et al. (2023) | Lacosamidea | 0.665, 0.534 | 0.596 | Human Nav1.7 |
| 8S9C | 40239 | N6W | Wu et al. (2023) | Carbamazepine | 0.56 | 0.577 | Human Nav1.7 |
| 8G1A | 29665 | P0T | Huang et al. (2023a) | Cannabidiol | 0.491, 0.364 | 0.573 | Human Nav1.7 |
| 8THH | 41262 | IYJ | Huang et al. (2023b) | Lamotriginea | 0.589, 0.456 | 0.615 | Human Nav1.7 |
| 8THG | 41261 | 657 | Huang et al. (2023b) | Riluzolea | 0.582 | 0.584 | Human Nav1.7 |
| 7WE4 | 32439 | 95T | Huang et al. (2022) | A-803467 | 0.659 | 0.609 | Human Nav1.8 |
| PDB ID | Emd ID | Drug ID | Reference | Drug name | Drug Qscores | Ave.pore Qscores | Subtype |
|---|---|---|---|---|---|---|---|
| 32341 | 966 | Bulleyaconitine A | 0.391 | 0.52 | Human Nav1.3 | ||
| 32343 | 8DE | ICA-121431 | 0.409 | 0.489 | Human Nav1.3 | ||
| 20949 | K4D | Flecainide | 0.557 | rat Nav1.5 | |||
| 942 | QDN | Quinidine | 0.529 | Human Nav1.5 | |||
| 31519 | 4Y4 | Propafenone | 0.556 | 0.57 | rat Nav1.5 | ||
| 28887 | XHO | Ranolazine | 0.512 | 0.556 | rat Nav1.5 | ||
| 41071 | YIJ | Batrachotoxin, Analog BTX-B | 0.253, 0.31 | 0.545 | rat Nav1.5 | ||
| 33292 | G2E | XEN-907 | 0.483 | 0.541 | Human Nav1.7 | ||
| 33295 | G2W | IN2 | 0.463 | 0.563 | Human Nav1.7 | ||
| 33296 | G4I | TCN-1752 | 0.57 | Human Nav1.7 | |||
| 35193 | OJ0 | Bupivacaine | 0.634 | Human Nav1.7 | |||
| 35194 | T70 | PF-05089771 | 0.64 | 0.647 | Human Nav1.7 | ||
| 35197 | T7F | Vinpocetine | 0.494 | 0.604 | Human Nav1.7 | ||
| 35198 | TB4 | Vixotrigine | 0.577 | 0.657 | Human Nav1.7 | ||
| 35975 | UK0 | Hardwickii acid | 0.555 | 0.594 | Human Nav1.7 | ||
| 40238 | LQO | Lacosamide | 0.665, | Human Nav1.7 | |||
| 40239 | N6W | Carbamazepine | 0.56 | 0.577 | Human Nav1.7 | ||
| 29665 | P0T | Cannabidiol | 0.573 | Human Nav1.7 | |||
| 41262 | IYJ | Lamotrigine | 0.589, | 0.615 | Human Nav1.7 | ||
| 41261 | 657 | Riluzole | 0.582 | 0.584 | Human Nav1.7 | ||
| 32439 | 95T | A-803467 | 0.659 | Human Nav1.8 |
Q-scores were extracted from Electron Microscopy Data Bank (https://www.ebi.ac.uk/emdb/) validation reports. Q-scores are used as a measure of resolvability in regions of a cryo-EM map – smaller the q-score, the lower the resolvability.
Indicates the instances where the averaged q-score of the surrounding pore residues is lower than the drug’s q-score. Bold indicates drug molecules not bound in the pore, but rather identified below the intracellular gate.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.